DOYLESTOWN HOSPITAL — History
CCN 390203 | 3-year financial timeline | COVID resilience: 42/100
🛡️ Public data only — no PHI permitted on this instance.
$317M
Latest Revenue (FY2022)
+4.5%
Revenue CAGR (3yr)
-9.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $290M | $307M | $317M | +3.3% | +4.5% |
| Operating Expenses | $306M | $340M | $348M | +2.6% | +6.7% |
| Operating Margin | -5.3% | -10.6% | -9.8% | +7.4% | +0.0% |
| Net Income | $-16M | $-33M | $-31M | +4.3% | +0.0% |
| Licensed Beds | 271 | 247 | 247 | +0.0% | -4.5% |
| Total Patient Days | 52,226 | 52,461 | 52,758 | +0.6% | +0.5% |
| Medicare Day % | 37% | 40% | 40% | -0.7% | +3.0% |
| Medicaid Day % | 2% | 2% | 2% | -0.1% | +4.8% |
COVID Impact & Recovery
Resilience Score: 42/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.3% ($290M → $317M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+4.5%
This Hospital
+7.6%
State Avg
Latest Margin
-9.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $331M | -12.1% |
| FY2024 (proj) | $344M | -14.3% |
| FY2025 (proj) | $358M | -16.5% |